Nancy Olson
Psychiatric/Mental Health · New London, CTNPI 1376674721
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 189 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 25.8% of the total. Among psychiatric/mental health clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 189 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$809
- Alkermes, Inc.$646
- Vanda Pharmaceuticals Inc.$601
- Lundbeck LLC$549
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$340
- plus $562 from 4 others
What the payments were for
- Food & beverage$4,726100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 38 | $1,218 |
| Otsuka America Pharmaceutical, Inc. | 28 | $809 |
| Alkermes, Inc. | 28 | $646 |
| Vanda Pharmaceuticals Inc. | 32 | $601 |
| Lundbeck LLC | 31 | $549 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $340 |
| AbbVie | 9 | $242 |
| Corium, LLC | 5 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$125
- ABILIFY MAINTENA$112
- ABILIFY ASIMTUFII$112
- VRAYLAR$102
How this compares
$4,726 in reported general payments places this provider in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.
See all psychiatric/mental health providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $37,871 |
| VyvanseLisdexamfetamine Dimesylate | 19 | $7,204 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $1,008 |
| Clonazepam | 105 | $975 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 20 | $527 |
| Quetiapine Fumarate | 29 | $464 |
| Lamotrigine | 39 | $424 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 12 | $387 |
| Duloxetine Hcl | 21 | $336 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $262 |
| Mirtazapine | 14 | $244 |
| Zolpidem Tartrate ErZolpidem Tartrate | 11 | $217 |
| Zolpidem Tartrate | 13 | $139 |
| Alprazolam | 44 | $111 |
| Trazodone Hcl | 21 | $83 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $1,218 | $37,87119 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $83 | $7,20419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 679 psychiatric/mental health providers in Connecticut.
Other psychiatric/mental health in New London
- William KornegayNew London$7K
- Cristina MeehanNew Britain$224K
- Samantha MrazBridgeport$87K
- Philip FrickManchester$31K
- Gia SantoroWest Haven$25K
- Donna DraperDanbury$19K
- Zahida SairitupaDanbury$19K
- Hui HuNorwich$19K
- Patrick GagnonMilford$15K
- Max Greger-MoserNew Haven$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.